Knight Therapeutics's market cap is currently $409.67M. The company's EPS TTM is $-0.02899736; its P/E ratio is 3,754.55; Knight Therapeutics is scheduled to report earnings on November 6, 2025, and the estimated EPS forecast is gt;-0.01. See an overview of income statement, balance sheet, and cash flow financials.
